North Carolina
Go Back to Map ←North Carolina’s bioscience industry is an innovative and growing component of the overall U.S. economy. With a track record of generating high-quality jobs and steady growth, the bioscience industry has been a consistent engine for our economy and a key strength during past economic recessions. American innovation in bioscience helps support state and local communities in a variety of ways ranging from job creation, construction, tax revenues, and other economic impact values.
Driven by small-company innovators, the bioscience industry has also mobilized in an unprecedented manner to address the global COVID-19 pandemic, while continuing to develop other life-saving and life-enhancing products and services for the U.S. and the world. America’s bioscience industry as an innovator and economic driver has never been more important, both for our health and our economic stability.
View Facilities By District
| District | Total Facilities in District | View Facilities in District |
| GA07 | 1 |
Evecxia Therapeutics |
| NC02 | 6 |
Aer Therapeutics, Inc. Cypress Biopharma FUJIFILM Diosynth Biotechnologies Inhalon Biopharma, Inc PharmaDirections, Inc. SiNON Nano Sciences |
| NC04 | 20 |
501 Ventures Avicenna Biosciences, Inc. Bantam Pharmaceutical Bayer CropScience, Inc. Caeregen Therapeutics, LLC ChemoGenics Biopharma, LLC Citranvi Biosciences LLC Dignify Therapeutics, LLC Doron Therapeutics, Inc. Kowa Research Institute, Inc. Lamassu Pharma, LLC Mycovia Pharmaceuticals, Inc. NeuroGT, Inc. North Carolina Biotechnology Center North Carolina Life Sciences Organization (NCLifeSci) Pappas Capital, LLC Praetego, Inc. Ribogenics, Inc. Tellus Therapeutics Vestaron Corporation |
| NC05 | 1 |
Plakous Therapeutics |
| NC07 | 2 |
Alcami Corporation Cygnus Technologies, Inc |
| NC12 | 1 |
BioCytics, Inc. |
| NC13 | 1 |
GeneVentiv Therapeutics, Inc. |
| NC14 | 1 |
Milestone Pharmaceuticals Inc. |